$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-21-000352 Size: 6 KB 网页链接
$Recro制药(REPH)$ 8-K Current report, item 5.07 Accession Number: 0000950170-21-000037 Act: 34 Size: 201 KB 网页链接
$Recro制药(REPH)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-001503 Act: 33 Size: 1 KB 网页链接
$Recro制药(REPH)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001564590-21-019510 Act: 34 Size: 5 MB 网页链接
$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-21-000339 Size: 5 KB 网页链接
$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-21-000334 Size: 4 KB 网页链接
$Recro制药(REPH)$ DEF 14A Other definitive proxy statements Accession Number: 0001564590-21-015283 Act: 34 Size: 2 MB 网页链接
$Recro制药(REPH)$ PRE 14A Other preliminary proxy statements Accession Number: 0001564590-21-013024 Act: 34 Size: 1 MB 网页链接
$Recro制药(REPH)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-21-007949 Act: 34 Size: 12 KB 网页链接
$Recro制药(REPH)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-21-061088 Act: 33 Size: 461 KB 网页链接